Reply  by Mansour, Ziad et al.
LETTERS TO THE EDITOR
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1Regarding “Remote and local ischemic
preconditioning equivalently protects rat skeletal
muscle mitochondrial function during experimental
aortic cross-clamping”
Mansour et al1 showed that local and remote ischemic precon-
ditioning (LIPC and RIPC) protect skeletal muscle against isch-
emia reperfusion-inducedmitochondrial dysfunction during aortic
cross-clamping. Based on these results, the authors advocate a
broader use of RIPC in the setting of vascular surgery. Recently, we
performed a systematic review and meta-analysis of animal studies
investigating the effects of ischemic preconditioning on ischemia-
reperfusion injury (IRI) of the kidney.2 Our analysis showed that
LIPC and RIPC are equally effective in the protection against renal
IRI and therefore support the conclusion by Mansour et al1 that
LIPC and RIPC equivalently protects against skeletal muscle IRI.
To date, no studies (animal or human) have investigated the
effect of aging, medication, and comorbidities such as diabetes,
hypertension, or obesity on RIPC in skeletal muscle or renal IRI.
For the heart, it has been shown that aging, medication, and
comorbidities influence ischemic preconditioning efficacy.3 In the
study by Mansour et al,1 and also in the majority of other animal
studies investigating the effects of ischemic preconditioning,
healthy young adult animals have been used. Therefore, the ques-
tion arises whether the efficacy of RIPC holds for patients with
cardiovascular (co)-morbidity. In our view, testing of suboptimal
RIPC protocols in large clinical trials could unnecessarily delay
implementation into routine clinical practice, due to marginal or
negative results.
Interestingly, our meta-analysis also revealed that the “late
window of protection” (RIPC 24 hours before index ischemia)
was more effective as compared to the “early window of protec-
tion” (RIPC 24 hours). Therefore, activation of both (early and
late) windows of protection by RIPCmight also result in improved
protection against IRI of human skeletal muscle and other target
organs. Because patients undergoing major vascular surgery are
exposed to a significant risk of myocardial and renal IRI, we believe
that the RIPC protocol should be optimized for different target
organs in vascular patients. Almost all clinical trials currently reg-
istered at http://Clinicaltrials.gov investigating the effects of
RIPC use the early window of protection. To our knowledge, data
on the efficacy of combined activation of the early and late window
in humans are lacking. Therefore, we believe that further (pre)clin-
ical research is required to optimize the RIPC protocol in cardio-
vascular patients before a broader implementation in vascular
surgery.
Theo P. Menting, MD
Kimberley E. Wever, MSc
J. A. (Daan) van der Vliet, MD, PhD
Michiel C. Warlé, MD, PhD
Department of Surgery, Division of Vascular and
Transplant Surgery
Radboud University Nijmegen Medical Center
Nijmegen, The Netherlands
REFERENCES
1. Mansour Z, Bouitbir J, Charles AL, Talha S, Kindo M, Pottecher J, et al.
Remote and local ischemic preconditioning equivalently protects rat
skeletal muscle mitochondrial function during experimental aortic cross-
clamping. J Vasc Surg 2012;55:497-505.
896. Wever KE, Menting TP, Rovers M, van der Vliet JA, Rongen GA,
Masereeuw R, et al. Ischemic preconditioning in the animal kidney, a
systematic review and meta-analysis. PLoS One 2012;7:e32296.
. Przyklenk K. Efficacy of cardioprotective ‘conditioning’ strategies in
aging and diabetic cohorts: the co-morbidity conundrum. Drugs Aging
2011;28:331-43.
ttp://dx.doi.org/10.1016/j.jvs.2012.04.059
eply
We appreciate Dr Menting and colleague’s comments and
greement on the fact that local and remote ischemic precondi-
ioning (IPC and rIPC) proved equivalent protection on skeletal
uscle and kidneys during ischemia-reperfusion. A similar protec-
ion was also observed on other target organs.1-3 Further, unlike
ostconditioning,4 IPC and rIPC have not been demonstrated to
e deleterious on skeletal muscle.
Nevertheless, whether efficacy of IPC and rIPC holds true in
ascular patients characterized by comorbidities remains a signifi-
ant issue because conditioning-related cardioprotective proper-
ies appeared reduced in presence of diabetes, hypercholesterol-
mia, or older age. Additionally, specific organ sensitivity to
schemia-reperfusion, oxidative stress, and inflammation might
lso be key limiting factors of IPC and rIPC protective effects.
hus, a protocol algorithm might well protect one organ and not
he others.
Should we therefore wait until all light to be made on the
echanisms involved in IPC and rIPC beneficial effects and on
ventual ischemic preconditioning drawbacks? As suggested by
enting et al, a way to overcome such potential limitations might
e combination use of both early and late windows of protection.
ombined ischemic conditioning and pharmacologic approaches
ight also be useful to optimize conditioning protocols.
In the clinical setting, Ali et al5 proved in a randomized
ontrolled trial that rIPC reduced myocardial and renal injury after
bdominal aortic cross-clamping for elective abdominal aortic
neurysm repair. Despite comorbidities, preconditioned patients
resented with better outcomes than not conditioned patients.
Acknowledging that experimental data are still needed and
hat, based on current evidence from small pilot trials, there are too
ew data to be able to say whether IPC has consistent beneficial
ffects,6 we nevertheless believe that implementation of personal-
zed IPC protocols should not be delayed into clinical practice.
arge scale controlled studies should be performed to determine
hether IPC will protect patients during their hospital stay, there-
ore improving their surgical overall outcomes.
iad Mansour, MD, PhD
ichel Kindo, MD, PhD
ulien Pottecher, MD
nne-Laure Charles, PhD
offrey Zoll, PhD
ernard Geny, MD, PhD
ouvel Hopital Civil
trasbourg, France
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Regarding “Factors affecting career choice among the
next generation of academic vascular surgeons”
I was delighted to read your Web survey of residents and their
choice for a career in academic vascular surgery in America.1 This is
indeed one of the few studies examining the actual factors that
influence a young vascular surgeon’s choice in embarking on an
academic and educational career. There are similar parallels with
the career choices of young vascular surgeons in the United
Kingdom to those of your study.
In the United Kingdom, there is a new academic pathway
where, from a medical school perspective, students can embark on
an academic foundation program, which enables them throughout
their first and second years post-medical school to embark on an
academic theme throughout their training. They are then encour-
aged to apply for an academic clinical fellow job where they will
pursue a high degree such as a Doctorate in Medicine (MD) or a
Doctorate of Philosophy (PhD). Following on from this extended
period of 2 to 3 years of research and on embarking on a vascular or
general surgical rotation, they can then apply to become an aca-
demic clinical lecturer. The role of an academic clinical lecturer is
to practice and learn surgery 50% of the time and continue aca-
demic pursuits in the other 50%. This is for approximately 4 years,
and during this period, grants are attained to further the young
surgeons’ academic interests and projects as well as supervising
projects of BSc, PhD, and MD students.
The only limitation with this new run-through academic train-
ing is the fact that clinical training is reduced in comparison with a
nonacademic training. Also, the uncertainty of becoming a senior
lecturer at an institution is always there in the back of the mind.
However, embarking on these career pathways also offers some
stability because they are usually based in one particular unit in the
hospital, and, usually due to affiliations within the department, it is
likely that one will take up a permanent post in the department if
one is available.
I myself am interested in an academic vascular surgical career;
however, I am not entirely convinced of the quality and quantity of
clinical training in these posts. These posts appeared to be adopted
by a similar proportion of males and females. However, the num-
bers who wish to embark on an academic vascular surgical career
are small throughout the United Kingdom. With centralization of
services and reduced hours, we are finding clinical training more
and more extremely difficult. What do the authors feel about
embarking on a traditional surgical career and then having an
academic interest as many have done in the past?
i
shiva Dindyal, BSc, MB BS, MRCS
arts and The London NHS Trust
he Royal London Hospital
ondon, United Kingdom
EFERENCE
. Danczyk RC, Sevdalis N, Woo K, Hingorani AP, Landry GJ, Liem
TK, et al. Factors affecting career choice among the next generation of
academic vascular surgeons. J Vasc Surg 2012;55:1509-14.
ttp://dx.doi.org/10.1016/j.jvs.2012.04.061
eply
We appreciate the informative letter. There are indeed many
arriers to preparing for and succeeding in an academic career.
hile some such barriers are somewhat generic (ie, common to all
urgeons), others may be institution- and country-specific. Mech-
nisms to overcome these barriers are also likely to be both generic
nd institution- and country-specific. Our study examined what
re, in essence, generic factors important to vascular trainees when
eciding whether to choose a career in academic vascular surgery
nd suggests that young vascular surgeons entering the academic
rena desire mentorship, research and teaching opportunities, a
linically busy practice offering a variety of open and endovascular
rocedures, and the ability to work with like-minded individuals.
owever, the unfortunate reality is that, in the last decade,
edical institutions in the United States have placed more
mphasis on clinical productivity, as it generates funding for the
ospital and the medical school. This drive to increase clinical
ctivity has had the effect of making it more difficult for aca-
emic surgeons in the United States to also engage in and excel
n research and teaching activities.
Creating divergent pathways for academic and clinical training
s outlined in the letter is a potential solution to the pressures of
rying to excel in both academic and clinical endeavors, provided
oth tracks are equally valued within institutions. However, in our
pinion, for a surgeon, academic excellence should not come at the
xpense of clinical competence. Clinical competence is always
aramount. If the program outlined in the letter, combined with
ocal barriers to training, does not permit training of a clinically
ompetent and confident surgeon, the new paradigmwill either fail
r result in two classes of surgeons within the United Kingdom.
bviously, both are undesirable outcomes. Similar to the new 0/5
raining paradigm for vascular surgeons in the United States, the
nited Kingdom academic pathway will require careful ongoing
ssessment and re-evaluation. It is my hope that leaders in surgical
ducation worldwide remain keenly aware of the angst facing the
urgeon contemplating an academic career and engage young
eople in finding local solutions to common problems.
rica Leith Mitchell, MD
regon Health and Science University
ortland, Oregon
ttp://dx.doi.org/10.1016/j.jvs.2012.05.005
egarding “Long-term incidence of myocardial
nfarct, stroke, and mortality in patients operated on
or abdominal aortic aneurysms”
We have read with keen interest the article by Eldrup et al1 on
he long-term incidence ofmyocardial infarction, stroke, and death
n patients operated on for abdominal aortic aneurysm (AAA). The
tudy is based on an impressive series of 11,094 patients who
